Literature DB >> 16845586

Elongation factor 1A family regulates the recycling of the M4 muscarinic acetylcholine receptor.

Daniel B McClatchy1, Guofu Fang, Allan I Levey.   

Abstract

In this study, we tested the hypothesis that the elongation 1A (eEF1A) family regulates the cell surface density of the M4 subtype of the muscarinic acetylcholine receptors (mAChR) following agonist-induced internalization. Here, we show that mouse brains lacking eEF1A2 have no detectable changes in M4 expression or localization. We, however, did discover that eEF1A1, the other eEF1A isoform, is expressed in adult neurons contrary to previous reports. This novel finding suggested that the lack of change in M4 expression and distribution in brains lacking eEF1A2 might be due to compensatory effects of eEF1A1. Supporting this theory, we demonstrate that the overexpression of either eEF1A1 or eEF1A2 inhibits M4 recovery to the cell surface after agonist-induced internalization in PC12 cells. Furthermore, eEF1A1 or eEF1A2 had no effect on the recovery of the M1 subtype in PC12 cells. These results demonstrate the novel ability of the eEF1A family to specifically regulate the M4 mAChR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845586     DOI: 10.1007/s11064-006-9103-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  53 in total

1.  A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away.

Authors:  N M Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Novel interaction between the M4 muscarinic acetylcholine receptor and elongation factor 1A2.

Authors:  Daniel B McClatchy; Charlotte R Knudsen; Brian F Clark; Richard A Kahn; Randy A Hall; Allan I Levey
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

3.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

4.  Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission.

Authors:  L Mrzljak; A I Levey; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Authors:  T T Cao; H W Deacon; D Reczek; A Bretscher; M von Zastrow
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

7.  The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein.

Authors:  S Kahns; A Lund; P Kristensen; C R Knudsen; B F Clark; J Cavallius; W C Merrick
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

8.  Identification of Gbetagamma binding sites in the third intracellular loop of the M(3)-muscarinic receptor and their role in receptor regulation.

Authors:  G Wu; G S Bogatkevich; Y V Mukhin; J L Benovic; J D Hildebrandt; S M Lanier
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  Sequestration of muscarinic acetylcholine receptor m2 subtypes. Facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2.

Authors:  H Tsuga; K Kameyama; T Haga; H Kurose; T Nagao
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  Internalization of the M2 muscarinic acetylcholine receptor proceeds through an atypical pathway in HEK293 cells that is independent of clathrin and caveolae.

Authors:  A G Roseberry; M M Hosey
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

View more
  8 in total

Review 1.  Synthesis, trafficking, and localization of muscarinic acetylcholine receptors.

Authors:  Neil M Nathanson
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

2.  Effects of two elongation factor 1A isoforms on the formation of gephyrin clusters at inhibitory synapses in hippocampal neurons.

Authors:  Michal Becker; Jochen Kuhse; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2013-07-10       Impact factor: 4.304

Review 3.  Modulation of M4 muscarinic acetylcholine receptors by interacting proteins.

Authors:  Ming-Lei Guo; Li-Min Mao; John Q Wang
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

4.  Overexpression of eukaryotic elongation factor 1 alpha-2 is associated with poorer prognosis in patients with gastric cancer.

Authors:  Song Yang; Mingdian Lu; Yuanyuan Chen; Delong Meng; Ruochuan Sun; Dapeng Yun; Zhijie Zhao; Daru Lu; Yongxiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-20       Impact factor: 4.553

Review 5.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

6.  Elongation factor 3, EF3, associates with the calcium channel Cch1 and targets Cch1 to the plasma membrane in Cryptococcus neoformans.

Authors:  Min Liu; Angie Gelli
Journal:  Eukaryot Cell       Date:  2008-05-23

7.  Translational control by RGS2.

Authors:  Chau H Nguyen; Hong Ming; Peishen Zhao; Lynne Hugendubler; Robert Gros; Scot R Kimball; Peter Chidiac
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

8.  Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin.

Authors:  Alejandro Losada; María José Muñoz-Alonso; Carolina García; Pedro A Sánchez-Murcia; Juan Fernando Martínez-Leal; Juan Manuel Domínguez; M Pilar Lillo; Federico Gago; Carlos M Galmarini
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.